Bringing Innovative Weapons To the Cancer Battlefront

What if we could engineer “killer cells” to wage war on tumors, and then program the little soldiers to seek a specific kill zone? What if glowing tumors could tell doctors which tissue material to remove during surgery?

These are just two of the recent breakthroughs in cancer research being undertaken by the hundreds of local bio- tech firms that are pumping money and resources into the oncology market — a market that’s booming with players, ...

Continue →
0

Startup Conducts Unusual Funding ‘Experiment’

A local biotech startup and its 22 year old CEO — with support of local industry veterans — are trying a no-strings-attached funding model to finance their research on a potential cancer vaccine.

“If we raise money at this point in the preclinical stages, the venture capitalists or investors are going to take a large portion of our shares,” President and CEO Samuel Wagner said. “If ...

Continue →
0

Batu Biologics Files IND Application for ValloVax

Batu Biologics Submits Investigational New Drug Application For Lung Cancer Anti-Angiogenic Immunotherapy with FDA

Batu Biologics, a biotechnology company focusing on developing therapies that target the Achilles Heel of Cancer: the tumor blood vessels, announced today the filing of an Investigational Drug Application (IND) with the U.S. Food and Drug Administration (FDA) for its lead immune therapy, ValloVax.

Read the full article at businesswire.com

Continue →
0

Awarded Exclusive License from UC San Diego

Batu Biologics Awarded Exclusive License from University of California San Diego for Drug That Stimulates Immune System to Kill Cancer
Biotech Start Up Expands its Oncology Immunotherapeutic Product Pipeline

Productive and beneficial relationships with cutting-edge pharmaceutical companies such as Batu Biologics help speed further development of promising new drugs to those most in need.

Read the full article at businesswire.com

Continue →
0

Batu Biologics Names Chief Scientific Officer

Batu Biologics Names Business Development and R&D Expert as Chief Scientific Officer
International Biotech Market Expert Will Help Boost Company’s Business Strategy

Her impeccable clinical trials expertise, combined with stellar interpersonal skills and keen knowledge of international markets, will serve the company well in its quest to be the first to successfully launch an anti-angiogenic lung cancer vaccine on the market.

Read the full article at businesswire.com

Continue →
0
Page 3 of 5 12345